These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 3109725

  • 1. Selecting initial therapy for bladder cancer.
    Soloway MS.
    Cancer; 1987 Aug 01; 60(3 Suppl):502-13. PubMed ID: 3109725
    [Abstract] [Full Text] [Related]

  • 2. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
    Soloway MS, Jordan AM, Murphy WM.
    Prog Clin Biol Res; 1989 Aug 01; 310():215-36. PubMed ID: 2505268
    [Abstract] [Full Text] [Related]

  • 3. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS.
    Urology; 1988 Mar 01; 31(3 Suppl):5-16. PubMed ID: 3126593
    [Abstract] [Full Text] [Related]

  • 4. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R, Selph S, Buckley DI, Fu R, Griffin JC, Grusing S, Gore JL.
    J Urol; 2017 May 01; 197(5):1189-1199. PubMed ID: 28027868
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant intravesical therapy for superficial bladder cancer.
    Batts CN.
    Ann Pharmacother; 1992 Oct 01; 26(10):1270-6. PubMed ID: 1421654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravesical chemotherapy: how effective is it?
    Heney NM.
    Urology; 1988 Mar 01; 31(3 Suppl):17-9. PubMed ID: 3126591
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M, Olaru V.
    Minerva Urol Nefrol; 2012 Dec 01; 64(4):255-60. PubMed ID: 23288212
    [Abstract] [Full Text] [Related]

  • 13. Managing superficial bladder cancer: an overview.
    Soloway MS.
    Urology; 1992 Dec 01; 40(6 Suppl):5-10. PubMed ID: 1466119
    [Abstract] [Full Text] [Related]

  • 14. Current concepts in the management of superficial bladder cancer.
    Soloway MS.
    Arch Esp Urol; 1990 Dec 01; 43 Suppl 2():115-21. PubMed ID: 2129003
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer.
    Chen CH, Yang HJ, Shun CT, Huang CY, Huang KH, Yu HJ, Pu YS.
    Urol Oncol; 2012 Dec 01; 30(4):421-7. PubMed ID: 20870427
    [Abstract] [Full Text] [Related]

  • 20. Treatment of superficial bladder cancer with intravesical chemotherapy.
    Badalament RA, Farah RN.
    Semin Surg Oncol; 1997 Dec 01; 13(5):335-41. PubMed ID: 9259089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.